Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Roth

Showing results (251-260 of 396) with videos related to

Pageof 40
Sort By:
Sleep Health|March 9, 2020
Mindfulness and nocturnal rumination are independently associated with symptoms of insomnia and depression during pregnancyDavid A Kalmbach, Thomas Roth, Philip Cheng, et al.
Journal of Clinical Psychopharmacology|September 3, 2014
A generalized estimating equation approach to analysis of maintenance of wakefulness testing in a study of lisdexamfetamine dimesylate, armodafinil, and placebo in sleep-deprived adultsThomas Roth, Jon Freeman, Gary Zammit, et al.
Sleep|November 29, 2007
Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomniaThomas Roth, Roberta Rogowski, Steven Hull, et al.
Sleep|November 25, 2010
Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary InsomniaAndrew D Krystal, H Heith Durrence, Martin Scharf, et al.
Journal of Comparative Effectiveness Research|August 1, 2024
Improvements in daytime sleepiness and disrupted nighttime sleep with once-nightly sodium oxybate in people with narcolepsy type 1 and type 2: a plain language summaryYves Dauvilliers, Thomas Roth, Richard Bogan, et al.
Clinical Therapeutics|July 25, 2006
Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adultsThomas Roth, David White, Wolfgang Schmidt-Nowara, et al.
Sleep Disorders|October 9, 2015
Perceived Immune Status and Sleep: A Survey among Dutch StudentsAnouk A M T Donners, Marilou D P Tromp, Johan Garssen, et al.
Journal of Opioid Management|September 4, 2012
Postsurgical patient-controlled opioid self-administration is greater in hospitalized abstinent smokers than nonsmokersCaren L Steinmiller, Christina Diederichs, Timothy A Roehrs, et al.
Sleep Health|April 9, 2026
Identifying major life events associated with insomnia disorder: Stressors that disrupt safety, stability, and identityMatthew B Jennings, David A Kalmbach, Philip Cheng, et al.
Sleep|May 17, 2003
Sleep during titration predicts continuous positive airway pressure complianceChristopher L Drake, Ryan Day, David Hudgel, et al.
Pageof 40

Showing results (251-260 of 396) with videos related to

Sort By:
Pageof 40
Sleep Health|March 9, 2020
Mindfulness and nocturnal rumination are independently associated with symptoms of insomnia and depression during pregnancyDavid A Kalmbach, Thomas Roth, Philip Cheng, et al.
Journal of Clinical Psychopharmacology|September 3, 2014
A generalized estimating equation approach to analysis of maintenance of wakefulness testing in a study of lisdexamfetamine dimesylate, armodafinil, and placebo in sleep-deprived adultsThomas Roth, Jon Freeman, Gary Zammit, et al.
Sleep|November 29, 2007
Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomniaThomas Roth, Roberta Rogowski, Steven Hull, et al.
Sleep|November 25, 2010
Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary InsomniaAndrew D Krystal, H Heith Durrence, Martin Scharf, et al.
Journal of Comparative Effectiveness Research|August 1, 2024
Improvements in daytime sleepiness and disrupted nighttime sleep with once-nightly sodium oxybate in people with narcolepsy type 1 and type 2: a plain language summaryYves Dauvilliers, Thomas Roth, Richard Bogan, et al.
Clinical Therapeutics|July 25, 2006
Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adultsThomas Roth, David White, Wolfgang Schmidt-Nowara, et al.
Sleep Disorders|October 9, 2015
Perceived Immune Status and Sleep: A Survey among Dutch StudentsAnouk A M T Donners, Marilou D P Tromp, Johan Garssen, et al.
Journal of Opioid Management|September 4, 2012
Postsurgical patient-controlled opioid self-administration is greater in hospitalized abstinent smokers than nonsmokersCaren L Steinmiller, Christina Diederichs, Timothy A Roehrs, et al.
Sleep Health|April 9, 2026
Identifying major life events associated with insomnia disorder: Stressors that disrupt safety, stability, and identityMatthew B Jennings, David A Kalmbach, Philip Cheng, et al.
Sleep|May 17, 2003
Sleep during titration predicts continuous positive airway pressure complianceChristopher L Drake, Ryan Day, David Hudgel, et al.
Pageof 40